Discovery of a Novel Inhibitor Structure of Mycobacterium tuberculosis Isocitrate Lyase
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27082447
Abstract: Tuberculosis remains a global threat to public health, and dormant Mycobacterium tuberculosis leads to long-term medication that is harmful to the human body. M. tuberculosis isocitrate lyase (MtICL), which is absent in host cells, is… read more here.
Keywords: tuberculosis; mycobacterium tuberculosis; isocitrate lyase; tuberculosis isocitrate ... See more keywords